Small Pharma Ltd, London

Small Pharma Ltd is a private limited company. Located at 50 Featherstone Street, London EC1Y 8RT, this 9 years old enterprise was incorporated on 2015-02-04 and is officially categorised as "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110).
1 director can be found in the company: George T. (appointed on 01 September 2015).
About
Name: Small Pharma Ltd
Number: 09420724
Incorporation date: 2015-02-04
End of financial year: 28 February
 
Address: 50 Featherstone Street
London
EC1Y 8RT
SIC code: 72110 - Research and experimental development on biotechnology
Company staff
People with significant control
Cybin Inc.
23 October 2023
Address 100 King St. West, Suite 5600, M5x 1c9, Toronto, Ontario, Canada
Legal authority Ontario
Legal form Corporation
Country registered Canada
Place registered Ontario
Registration number 5020165
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors
Peter R.
4 February 2017 - 29 April 2021
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors
Financial data
Date of Accounts 2019-02-28 2020-02-28
Current Assets 170,410 457,476
Total Assets Less Current Liabilities 143,678 440,201

The target date for Small Pharma Ltd confirmation statement filing is 2024-02-18. The previous confirmation statement was sent on 2023-02-04. The due date for the next accounts filing is 30 November 2024. Latest accounts filing was sent for the time up until 28 February 2023.

2 persons of significant control are reported in the Companies House, namely: Cybin Inc. has over 3/4 of shares, 3/4 to full of voting rights. The corporate PSC can be reached at King St. West, Suite 5600, M5X 1C9, Ontario. Peter R. who has over 3/4 of shares, 3/4 to full of voting rights.

Company filing
Filter filings by category:
Accounts Address Annual return Capital Change of name Confirmation statement Incorporation Officers Persons with significant control Resolution
Extension of current accouting period to March 31, 2024
filed on: 15th, December 2023 | accounts
Free Download (1 page)